No significant risk of resistance if HIV infection occurs during use of Truvada PrEP
PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors
HIV incidence is high among pregnant and postpartum women and increases the risk of mother-to-child transmission
Dapivirine vaginal ring safe and effective in tissue study, but maraviroc component doesn't work
Very different levels of PrEP uptake and adherence in three US cities, demonstration project finds
Monkey studies confirm viability of injectable PrEP drug
